Autologous fat graft injections for the treatment of perianal fistulas in Crohn's disease: a systematic review and single-arm meta-analysis
- PMID: 36658773
- DOI: 10.1111/ans.18231
Autologous fat graft injections for the treatment of perianal fistulas in Crohn's disease: a systematic review and single-arm meta-analysis
Abstract
Background: Crohn's perianal fistulas are often refractory to standard management. Fat graft injections are hypothesised to improve fistula healing rates. We evaluated the treatment efficacy of fat graft injections for Crohn's perianal fistulas in a systematic review (PRISMA).
Methods: We completed database searches of MEDLINE (Ovid), Embase, and PubMed. All studies published in English in full text or abstract, from January 2001 to August 2021, evaluating fat graft injections for Crohn's perianal fistulas were selected. Included randomized controlled trials, single-arm intervention trials, cohort studies, and case series; excluded single case reports. Primary outcome was pooled clinical healing, defined as non-draining treated fistulas, or closure, defined as closure of treated fistulas. Secondary outcomes were clinical healing, clinical closure, radiologic response, and adverse events.
Results: Of 1258 publications identified, 891 articles were assessed for eligibility, and 107 relevant for manuscript review. Forty-nine patients received fat graft injections for Crohn's perianal fistulas across four single-arm intervention trials. Clinical healing or closure was achieved in 74% in a pooled single-arm meta-analysis (95% confidence interval: 57%, 85%), with moderate heterogeneity between studies. Clinical healing was achieved in 20% and 60% at 3 and 12 months, respectively. Clinical closure was achieved in 83% at 6 months. Variable parameters were used to define radiologic response, with success rates from 20% to 67%. Minimal adverse events were reported.
Conclusion: Fat graft injections show promise as a novel treatment for Crohn's perianal fistulas in this systematic review and meta-analysis. Assessment in controlled matched studies is warranted.
Keywords: Crohn's disease; fat graft; metaanalysis; perianal fistula; systematic review.
© 2023 Royal Australasian College of Surgeons.
Comment in
-
Re: Autologous fat graft injections for the treatment of perianal fistulas in Crohn's disease: a systematic review and single-arm meta-analysis.ANZ J Surg. 2023 Dec;93(12):3028. doi: 10.1111/ans.18731. Epub 2023 Oct 19. ANZ J Surg. 2023. PMID: 37859566 No abstract available.
References
-
- Panés J, García-Olmo D, Van Assche G et al. Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn's disease. Gastroenterology 2018; 154: 1334-42.
-
- Laureti S, Gionchetti P, Cappelli A et al. Refractory complex Crohn's perianal fistulas: a role for autologous microfragmented adipose tissue injection. Inflamm. Bowel Dis. 2020; 26: 321-30.
-
- Liberati A, Altman DG, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. BMJ 2009; 6: 1-28.
-
- Munn Z, Barker TH, Moola S et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid. Synth. 2020; 18: 2127-33.
-
- Goplen CM, Verbeek W, Kang SH et al. Preoperative opioid use is associated with worse patient outcomes after total joint arthroplasty: a systematic review and meta-analysis. BMC Musculoskelet. Disord. 2019; 20: 234.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical